Morgan Stanley Finance Launches $251 Million Market-Linked Notes Backed by S&P 500 Futures Index

Issuance Overview and Guarantee Structure

Morgan Stanley Finance LLC (MSFL), a Morgan Stanley subsidiary, issued these notes under its Series A Global Medium-Term Notes program. The notes are unsecured obligations of MSFL and carry Morgan Stanley’s full and unconditional guarantee, extending repayment rights to the parent company. The aggregate principal issued totaled $251 million, comprising 251,000 notes at $1,000 each. The original issue date was July 23, 2026, following pricing on July 20, 2026, with the strike date also set for July 20, 2026. Maturity is scheduled for July 24, 2031, establishing a five-year investment term.

Morgan Stanley & Co. LLC acted as the offering agent, purchasing the notes for resale to fee-based advisory accounts. The agent acquired the notes at $995 each, selling them to an unaffiliated dealer at the same price, who then distributed them to fee-based advisory accounts at the public price of $1,000 per note. This pricing structure implied commissions and fees of $5 per note, totaling $1,255,000 on the issuance, with net proceeds to MSFL amounting to $249.745 million.

Index-Linked Returns and Participation Details

Returns on the notes are linked to the S&P 500 Futures Excess Return Index, measured from the strike date of July 20, 2026, to the observation date of July 21, 2031, subject to postponements for non-trading days or market disruptions. The initial index level was 595.63, based on the closing level on the strike date. At maturity, payment depends on whether the final index level exceeds the initial level.

If the final index level surpasses the initial level, investors receive their principal plus an upside payment calculated as the principal multiplied by 150% participation rate and the index’s percentage gain. For example, a 5% index appreciation would yield $1,075 per note, or 107.5% of principal. If the final level is equal to or below the initial level—such as a 15% decline—investors receive only the $1,000 principal with no additional return.

Principal Protection and Risk Mitigation

These notes provide principal protection, ensuring investors receive no less than the $1,000 stated principal at maturity regardless of index performance. This feature offers a safety net against significant index declines over the five-year period. The notes do not pay interest, reflecting their design as performance-linked instruments prioritizing potential capital appreciation over current income.

The offering is tailored for investors seeking equity exposure with downside protection who are willing to forgo interest payments. However, all payments are subject to Morgan Stanley’s credit risk. The notes are unsecured and not backed by collateral, meaning investors have no claim on specific assets in case of default.

Valuation, Pricing Methodology, and Embedded Costs

The estimated value at pricing was $975.50 per note, $24.50 below the $1,000 issue price, reflecting issuance, structuring, selling, and hedging costs borne by investors. Morgan Stanley’s valuation incorporated both a debt component and a performance-based component linked to the underlying index, using internal pricing models, market inputs, volatility assumptions, and interest rates.

The valuation includes an interest rate derived from Morgan Stanley’s secondary market credit spreads for fixed-rate debt. The internal funding rate used was likely lower than these spreads, benefiting the issuer. Morgan Stanley disclosed that if issuance costs were lower or the internal funding rate higher, economic terms would be more favorable to investors, highlighting the embedded value transfer.

Secondary Market Pricing and Liquidity

Secondary market purchase prices by Morgan Stanley & Co. may be lower than the estimated value at pricing due to credit spreads and bid-ask spreads. Since issuance costs are not fully deducted upfront, secondary market prices during amortization are expected to exceed estimated values, barring market or credit spread changes.

Morgan Stanley & Co. may choose to make a market in the notes but is not obligated to do so and can cease market-making anytime. The notes are unlisted, limiting liquidity options. Investors should be prepared to hold the notes until maturity if secondary market trading is unavailable or unfavorable.

CUSIP and Regulatory Filings

The notes have CUSIP 61781G5U1 and ISIN US61781G5U16, enabling electronic settlement. The pricing supplement was filed under Rule 424(b)(2) on July 22, 2026, referencing registration statements 333-293641 and 333-293641-01. The documentation supplements product, index, tax supplements, and prospectus all dated April 8, 2026.

The SEC and state regulators have not approved or disapproved the notes or verified the documentation’s accuracy. The notes are not FDIC insured, are not bank deposits, and are not guaranteed by any bank despite Morgan Stanley’s bank holding company status.

Target Investors and Use of Proceeds

These notes are designed exclusively for fee-based advisory accounts, excluding commission-based or other account types. They suit investors concerned about principal risk seeking returns linked to index performance while foregoing current income. This profile targets advisory clients desiring equity exposure with downside protection.

Net proceeds of $249.745 million will fund hedge positions and cover guarantee and structuring costs, with funding and hedging influenced by secondary market credit spreads and market conditions.

Risk Factors and Investor Considerations

Investors face risks including receiving only principal if the index does not appreciate, no interest payments, and exposure to Morgan Stanley’s credit risk. Despite principal protection at the fund level, default by Morgan Stanley could lead to partial or total investment loss. The notes’ unsecured, uninsured nature requires careful credit risk assessment and consultation with financial advisors.

The notes combine derivative-like payoffs with unsecured debt status, presenting risks distinct from traditional debt securities.

Tax and Accounting Considerations

The April 8, 2026 tax supplement outlines federal income tax treatment, which may be complex. The notes could be treated as debt with embedded derivatives, triggering mark-to-market or forward contract accounting for certain investors. Income recognition timing and character may differ from conventional investments.

Investors should consult tax advisors regarding their specific circumstances, as tax treatment varies by investor type and may impact after-tax returns relative to alternatives.